Patents by Inventor Raphael Guerois

Raphael Guerois has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides that inhibit the interaction between ASF1 and histones, and use thereof
    Patent number: 9526757
    Abstract: The present invention relates to peptides capable of inhibiting the formation of the complex between the Asf1 histone chaperone and histones H3-H4, and to the use thereof as a drug, particularly for treating cancer.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: December 27, 2016
    Assignees: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, UNIVERSITE PIERRE ET MARIE CURIE (PARIS VI)
    Inventors: Francoise Ochsenbein, Raphael Guerois, Albane Gaubert, Regis Courbeyrette
  • PEPTIDES THAT INHIBIT THE INTERACTION BETWEEN ASF1 AND HISTONES, AND USE THEREOF
    Publication number: 20150025016
    Abstract: The present invention relates to peptides capable of inhibiting the formation of the complex between the Asf1 histone chaperone and histones H3-H4, and to the use thereof as a drug, particularly for treating cancer.
    Type: Application
    Filed: November 16, 2012
    Publication date: January 22, 2015
    Inventors: Francoise Ochsenbein, Raphael Guerois, Albane Gaubert, Regis Courbeyrette
  • Chemical structure having an affinity for a phospholipid and labeling compound diagnose kit and drug comprising this structure
    Patent number: 6979554
    Abstract: The present invention relates to a compound having affinity for a negatively charged phospholipid as well as to a detection molecule, to a conjugate and to a pharmaceutical composition comprising said compound. Generally speaking, the compound of the present invention is useful for specific recognition of lipid vectors. It may be used in engineering and in the generation of compound for recognizing and sequestrating of negatively charged lipids, such as phosphatidyl-serine and phosphatidic acid. The chemical structure of the present invention may have the construction (I).
    Type: Grant
    Filed: September 30, 1999
    Date of Patent: December 27, 2005
    Assignees: Commissariat a l'Energie Atomique, Universite Pierre et Marie Curie (Paris VI)
    Inventors: Alain Sanson, Françoise Russo-Marie, Jean-Michel Neumann, Françoise Cordier-Ochsenbein, Raphael Guerois